![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 17, 2017 3:14:52 PM
Also, that is why I will never understand why a company with a breakthrough technology like the 3d bioreactor with its many patents, didn't start trying to capitalize on their invention years ago. That's usually what companies do isn't it? Would have been ready for the boom in cell manufacturing for the biotech industry like Lonza is. 27% growth in the first half from there cell manufacturimg division. (Number may be off slightly as that's what I remember seeing when I checked). And this is just the beginning of the biotech boom that is coming.
Hence why I think these twins are over their head and truthfully don't understand how anyone doesn't see that. May work out great in our trials and all still be happy, but a giant opportunity was missed by our management. And we lost 2 years of product development time building out our almost idle facility. If a stockpiling contract does come, at least that will start the bioreactors going.
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM